Introduction
Sixty trillion (6 ϫ 10 13 ) cells in the human body share essentially identical genomic DNA. Nonetheless, for normal physiological function distinct for each cell type, expression of genes is tightly regulated by the cell lineage. It is, therefore, critical to uncover which genes are specifically expressed by individual cell types for further understanding of cell biology and body function.
Mesangial cells play a central role in maintaining a structure and function of the glomerulus. In the pathophysiology of glomerular diseases, the proliferation of mesangial cells and the accumulation of extracellular mesangial matrix are primary events leading to the progression to glomerulosclerosis in patients with a variety of glomerular disorders, such as chronic glomerulonephritis and diabetic nephropathy, two major causes of end-stage renal failure.
To determine and characterize mesangium-specific genes is, therefore, essential to understand the pathogenesis of glomerular diseases. We used a novel strategy using a rapid largescale DNA sequencing and computerized data processing for this purpose. Here we report cloning and characterization of a new human mesangium-predominant gene, megsin, which was a new member of the serpin superfamily and was upregulated in IgA nephropathy, a form of mesangial proliferative glomerulonephritis.
Methods
Construction of the 3 Ј -directed mesangium cDNA library. Details of construction of the cultured human mesangial cell library have been described elsewhere (1) . Briefly, human glomeruli were isolated by differential sievings from a normal human kidney obtained from surgical specimens obtained during nephrectomy in a 58-yr-old male with kidney tumor. Isolated glomeruli were resuspended in medium 199 (GIBCO BRL, Gaithersburg, MD) containing 25 mM Hepes, 10% Nu-serum (Collaborative Biomedical Products, Bedford, MA), and antibiotics (10 mg/ml of penicillin, streptomycin, and fungizone), and were incubated in a 5% CO 2 incubator. Mesangial cells at passage 3 were characterized by a series of criteria (1, 2) : typical morphologic features, tolerance to trypsin, puromycin and D-valine, positive immunostaining for ␣ -smooth muscle cell actin, and the absence of staining for von Willebrand factor, a marker for endothelial cells, and cytokeratine, a marker for parietal epithelial cells. Total RNA was isolated from human mesangial cells at passage 6 using the standard guanidine isothiocyanate method. PolyA ϩ RNA was isolated by oligo dT-cellulose column (Pharmacia, Tokyo, Japan) according to the manufacturer's protocol.
A vector primer is dam-methylated at the MboI sites (GATC) and has a 3 Ј protrusion of homo dT stretch at one end. The doublestranded cDNA moiety was cleaved with MboI. The vector that was attached with the 3 Ј -cDNA (from polyA to the nearest MboI site) was then circularized by ligation and was transformed into Escherichia coli . The resulting transformants were selected randomly and were lysed individually by brief boiling. The lysate was used as a template for PCR amplification. The resulting short double-stranded DNA was used for the cycle-sequencing reaction and was analyzed using an autosequencer.
Cloning of megsin. To identify the 5 Ј end of megsin cDNA, the 5 Ј -Full RACE Core Set (Takara, Tokyo, Japan) was used. The reverse transcriptase (RT)
1 reaction was performed with 1.0 g of hu-man mesangial cell polyA ϩ RNA with a gene-specific oligonucleotide, 5 Ј -pTCAGAGAGGTCATTC. After degradation of the template mRNA with RNase H, the first strand cDNA was circulated by T4 RNA ligase and an aliquot was used as a template for the first PCR amplification with gene-specific primers, P1 (5 Ј -AGATTCT-TGAGCTCAGAT) and P2 (5 Ј -TCATTGATGGGTCCTCAA). The resulting PCR product was then used as a template for the second PCR amplification with nested gene specific primers, P3 (5 Ј -AATG-GTGGCATAAACATG) and P4 (5 Ј -ACAGACAAATTGAAC-TTC). The PCR products were cloned into the pCRII vector (Clontech, Palo Alto, CA) and DNA sequences were determined by dideoxy chain termination reaction using a DNA autosequencer.
Expression of megsin fusion protein. Expression of megsin fusion protein was performed as follows. The entire coding sequence of megsin cDNA was obtained by RT-PCR. Single-strand cDNA was prepared from human mesangial cell polyA ϩ RNA using oligo (dT) primer and RT. The resulting first-strand cDNA was amplified using specific primers from the 5 Ј region and the 3 Ј region of the coding sequence, P5 (5 Ј -GTCGACTTATCAAGGGCAAGAAACTTTGCC) and P6 (5 Ј -GAATTCCATGGCCTCCCTTGCTGCAGCAAA) containing EcoRI and SalI recognition sequences at their 5 Ј end each. Amplified megsin DNA was cloned originally into pCRII vector (Clontech) for nucleotide sequencing, and then ligated into the maltose-binding fusion protein vector pMALc2 (New England Biolabs, Beverly, MA) using EcoRI and SalI site. Fusion protein was expressed in E. coli (DH5 ␣ ), affinity purified according to the manufacturer's instructions (New England Biolabs), and dissolved in 50 mM Tris-HCl, pH 9.0.
The fusion protein was then reacted with Endo Lys-C (Acromobacter Protease I, Wako Pure Chemicals, Osaka, Japan) (enzyme/ substrate ratio ϭ 1:50, W/W) at 37 Њ C for 8 h. The digested peptides were separated by high performance liquid chromatography (model LC-10A; Shimadzu, Kyoto, Japan) on a C18 reverse-phase column (4.6 ϫ 250 nm; Waters, Tokyo, Japan), detected by their absorbance at 214 nm, collected, and subjected to peptide sequencing on an automatic protein sequencer (Model 491 gas-phase sequencer; PerkinElmer, Chiba, Japan) or to SDS-PAGE using a 4-20% gradient acrylamide gel and Coomassie brilliant blue staining.
Analysis of the amino acid sequence. Motif search was performed using a Motif Finder program written by A. Ogiwara (Institute for Chemical Research, Kyoto University, Kyoto, Japan). This program searches PROSITE (3, 4) and MotifDic (5) . To find a signal sequence, we applied PSORT (K. Nakai, National Institute for Basic Biology, Japan), a program to predict protein localization sites. Sequence homology search was performed using the FASTA program (6) . Sequence alignment and pustell matrix comparison were performed according to the protein-scoring matrix pam250 with MacVector (International Biotechnologies, Inc., New Haven, CT). The Kyte-Doolittle scale (7) was used to investigate a hydrophilicity profile with MacVector. Secondary structure prediction was performed by PHD (Profile fed neural network system from Heidelberg) sec, according to the Rost and Sander secondary structure prediction method (8) .
Northern blot analysis. RNA of cultured human mesangial cells and fibroblasts was separated on a 1% agarose gel containing 2.2 M formamide and transferred to a nitrocellulose filter. The filter was hybridized in a Rapid Hyb solution (Amersham Corp., Arlington Heights, IL). Blot was washed to a final stringency of 0.1 ϫ SSPE/ 0.1% SDS at 60 Њ C.
A human multiple tissue Northern blot and a human cancer cell line Northern blot were purchased from Clontech. A human multiple tissue northern blot contains 2 g of polyA ϩ RNA from heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas. A human cancer cell line Northern blot has 2 g of polyA ϩ RNA from promyelocytic leukemia (HL-60), HeLa cell (S3), chronic myelogenous leukemia (K-562), lymphoblastic leukemia (MOLT-4), Burkitts' lymphoma (Raji), colorectal adenocarcinoma (SW480), lung carcinoma (A549), and melanoma (G361). Hybridization and washing was performed as described above.
RT-PCR. Total RNA was isolated from monocytes, polymorphonuclear leukocytes, cultured human mesangial cells, and other human primary cultured cells (vascular smooth muscle cells, fibroblasts, endothelial cells, renal epithelial cells, and keratinocytes) purchased from Takara (Tokyo, Japan) by guanidinium thiocynate-phenol-chloroform extraction. The RNA was reverse transcribed using a T-PrimedFirst-Strand kit (Pharmacia) according to the manufacturer's instructions.
PCR amplification was performed in 25 l reaction (with 1 ml of the reverse-transcribed products) containing 0.625 U of ExTaq (Takara), 200 mM each of the four deoxynucleoside triphosphates, 20 pmol of sense primer (5 Ј end), and 20 pmol of antisense primer (3 Ј end). The oligonucleotide primers for megsin sequences were: sense, 5 Ј -ATGATCTCAGCATTGTGAATG-3 Ј and antisense, 5 Ј -ACT-GAGGGAGTTGCTTTTCTAC-3 Ј . The expected size of the amplified fragment was 773 bp. The ␤ -actin served as an internal RNA control to allow comparison of RNA levels among different specimens. Specimens were amplified in a DNA Thermal Cycler (Perkin Elmer Cetus). Each cycle consisted of incubation for denaturation at 94 Њ C for 1 min, annealing at 60 Њ C for 2 min, and extension at 72 Њ C for 2 min. The PCR products were resolved by electrophoresis in a 1% agarose gel and visualized by ethidium bromide staining.
In situ hybridization. In situ hybridization was performed as described previously (9) . Nucleotide sequences from 391 to 428 of human megsin cDNA (5 Ј -AGCGTGGACTGAGGGAGTTGCTTT-TCTACAATATTACT-3 Ј ) were used as a probe. To evaluate the specificity of the signals, RNase pretreatment or a competitive study with 100-fold excess amount of homologous or unrelated, unlabeled oligonucleotides was performed. To quantitate the megsin mRNA expression, all nuclei and nuclei with surrounding positive cytoplasm in at least 10 randomly selected glomeruli (cross-section through their vascular poles) were blindly enumerated, and results were expressed as percentage of positive cells of total nuclei. Mann-Whitney U test was used for the statistical comparisons.
Results
Identification of a new human mesangium-specific gene. To identify specific gene(s) expressed in mesangial cells, we used a rapid large-scale DNA sequencing and computerized data processing to compare the transcripts in various different cells and organs (1, 10, 11) . A large scale sequencing of a 3 Ј -directed cDNA library of cultured human mesangial cells was performed to determine partial sequences of 1836 randomly picked clones. The sequence similarities of the clones were compared with each other and with the DNA databank GenBank using the FASTA program (6). We selected six clones that had not been recorded in any other databases and were thought to be predominantly expressed in mesangial cells. Dot blot analysis of mRNAs from various organs and cells supported mesangium-predominant expression of these clones (data not shown). One clone was obtained, which was most abundant among those detected only in our human mesangial cell cDNA library. This clone consisted of 0.3% of all the mRNA population.
The new gene, megsin, is a new member of the serpin superfamily. Using PCR techniques, a full length cDNA of this gene was obtained (Fig. 1) . The nucleotide sequencing analysis revealed an open reading frame of 1140 nucleotides coding for a predicted protein of 380 amino acids with four potential N -glycosylation sites (the deduced molecular weight, 43 kD). The sequence around the initiation codon (GCAATGG) was consistent with Kozak's consensus sequence (A/GCCATGG). Stop codons were in all three reading frames at the upstream of the initiation codon.
The size of the fusion protein produced by E. coli expression system was ‫ف‬ 85 kD (Fig. 2) , which was equivalent to the calculated molecular weight of the deduced amino acid sequence of the fusion protein with the maltose-binding protein (42 kD). The amino acid sequencing analysis of two Endo Lys-C-digested peptides of the fusion protein confirmed that this open reading frame was correct (single overlines in Fig. 1 ).
Amino acid homology search by the FASTA program throughout the SwissProt database revealed that this gene was highly homologous to members of the serpin superfamily (12) (13) (14) (15) (16) , which is a group of structurally related proteins and generally serves as extracellular, irreversible serine protease inhibitors. Squamous cell carcinoma antigen 1 (SCCA1) showed the highest homology to megsin (41.2% identity, see also Fig. 3 A ) , followed by other members of the serpin superfamily, including SCCA2 (40.6%), leukocyte elastase inhibitor (37.5%), and plasminogen activator inhibitor-2 (PAI-2) (35.2%). Therefore, we termed this gene megsin after mesangial cell-predominant gene with a homology to serpin.
Motif search of the amino acid sequence of megsin confirmed the serpin signature at the COOH terminus. Comparison with the other members of the serpin superfamily suggested that amino acids 331-352 corresponded to the reactive site loop (RSL) (P17 to P5 Ј ) (17-20) (a box in Fig. 1 and Fig. 3 B ) .
Northern blot analysis and RT-PCR confirmed that megsin was predominantly expressed in human mesangial cells.
By Northern blot analysis with a megsin cDNA probe, a single transcript of 3.0 kb was detected in cultured mesangial cells, but not in any other organs or cancer cell lines tested (Fig. 4  A ) . Although megsin transcript was detected in primary cultured human fibroblasts, the amount of the transcript was apparently much less than in mesangial cells (Fig. 4 B ) . The megsin transcripts were detected only in cultured human mesangial cells by RT-PCR at 20 cycles (Fig. 5 A ) . When the samples were amplified up to 40 cycles, faint bands corresponding to megsin could be observed in kidneys from two different subjects, some other primary cultured cells, and circulating cells (Fig. 5 B ) . Without reverse transcription, no bands could be detected (data not shown). These results demonstrated that megsin was predominantly expressed in human mesangial cells.
In situ hybridization studies demonstrated that expression of megsin was upregulated in the proliferating mesangium. The megsin mRNA expression was evaluated on human renal tissues from 18 patients with IgA nephropathy (IgA-N) and three normal kidneys by in situ hybridization. Patients with IgA-N were divided into two subgroups: those with mesangial cell proliferation with minimal glomerular sclerosis (proliferative stage, n ϭ 9) and those with glomerular sclerosis in Ͼ 30% of glomeruli (sclerotic stage, n ϭ 9). Megsin mRNAs were demonstrated exclusively in the glomeruli of both normal subjects (Fig. 6 A ) and IgA-N (Fig. 6 B ) . Within the glomeruli, megsin transcripts were detected in location consistent with mesangial cells (Fig. 6 C ) . Pretreatment of tissues with RNase before hybridization eliminated most of the signal detected with the megsin probe, and the megsin signals disappeared with a large amount of unlabeled homologous oligonucleotide competitors but not with nonhomologous oligonucleotides (data not shown). The number of positive cells for megsin in IgA-N of the proliferative stage was significantly greater than those in normal kidneys (Table I) .
Discussion
Using a novel approach entailing a rapid large-scale DNA sequencing and computerized data processing, we discovered a new human mesangium-predominant gene "megsin." Megsin was composed of 380 amino acids and was a new member of the serpin superfamily. Although some serpins have functions distinct from protease inhibition, three evidences suggest that megsin is an inhibitory serpin. First, the Peven residues of the megsin RSL were uncharged, small, and nonpolar, which is a characteristic feature of the inhibitory serpins. Second, inhibitory serpins have the sequence of Ala-Ala/Thr-Ala-Ala at the NH 2 -terminal region of the RSL (P12 to P9), called the hinge region. P12 to P9 of the RSL of megsin were ATAA. The P17-P8 sequence of megsin (EEGTEATAAT) was indeed consistent with the consensus sequence among inhibitory serpins (EEGTEAAAAT) (Fig. 3) . Third, it is known that the stretch of ␤ -sheet immediately precedes the NH 2 -terminal side of the RSL, which is a prerequisite for proteinase inhibition, and limits the sizes and charges of amino acids in the hinge region to achieve appropriate conformational change. Megsin preserved this ␤ -sheet stretch.
Residues flanking the putative scissile bonds within the RSL (P1 and P1 Ј ), which are thought to be important in determining the substrate specificity (21-23), were Lys-Gln. No other inhibitory serpins have related sequences at this site. Serpins such as the Kunitz type bovine basic protease inhibitor are known to have Lys at P1 and inhibit trypsin strongly. The target serine protease of megsin might be, therefore, a lysinecleaving protease. Hydrophilicity profile showed two hydrophobic regions in ␣ helix A (amino acids 1-16) and B (amino acids 22-44) of megsin (single underlines in Fig. 1 ), whereas we could find no apparent NH 2 -terminal signal peptide sequence. Several serpins appear to exist as dualistic molecules that can be either secreted or cytoplasmic, due to these noncleavable internal signal sequence in a helix A and B (24) (25) (26) (27) (28) . It is possible that these ␣ helix regions play important roles for translocation of megsin as dualistic molecules.
Northern blot analysis revealed the predominant expression of megsin in cultured human mesangial cells. Megsin transcript was not detected in poly A ϩ RNA from other cancer cells or organs tested by Northern blotting. Localization of megsin-producing cells in our in situ hybridization studies of human renal tissues from normal subjects and patients with IgA-N were consistent with mesangial cells. Furthermore, we cloned a megsin homologue from cultured rat mesangial cells, which were stained positive for Thy-1 antigen, a marker of rat mesangial cells (29) (our manuscript in preparation). These findings strongly suggest the predominant expression of megsin in mesangial cells.
Northern blot analysis did not detect megsin transcripts in human kidney samples, although RT-PCR analysis of human kidneys and some other primary cultured or circulating cells showed corresponding bands after the samples were amplified up to 40 cycles. One possible explanation for this discrepancy is due to the small number of mesangial cells in the kidney, which is also composed of endothelial cells, epithelial cells, and other various cells. Alternatively, cultured mesangial cells are known to acquire new phenotypes, and become more prone to proliferate or become activated (30, 31) . Our in situ hybridization studies demonstrated that the expression of megsin was upregulated in IgA-N of the proliferative stage. Therefore, it is more likely that expression of megsin is upregulated only when mesangial cells are activated. [37] ) were aligned. Nonpolar residues are shown in bold. P17-P8, indicated by a box, corresponds to the consensus sequence for inhibitory serpins (EEGTEAAAAT) (38) . ILEU, leukocyte elastase inhibitor; OVA, ovalbumin.
The mechanism of mesangium-predominant expression of megsin is another important subject to be pursued. Further studies of the promoter and transcriptional factor of megsin will give an important insight to a mechanism of cell typedependent gene expression. This information can also be useful in targeting specific cells when molecular genetics and gene transfer techniques are applied.
Furthermore, mesangium-predominant genes can also serve as biological markers for mesangial cells. Although Thy-1 antigen has been used to identify rat mesangial cells, rat Thy-1 antigen is also expressed by other cell lineages such as thymocytes and, more importantly, human mesangial cells lack this molecule (32) . Human mesangium-specific markers provide great tools to investigate glomerular diseases, which renders identification of megsin even more importance.
Sequence homology and similar biological activity of megsin with PAI-2 and other inhibitory serpins gives us a clue for its putative function. Serpins play a central role in the regulation of a wide variety of physiologic and pathological processes including coagulation, fibrinolysis, matrix metabolism, development, blood pressure, malignancy, and inflammation (14, 33) . Glomerulosclerosis results from accumulation of extracellular matrix proteins as a consequence of their increased synthesis and relative inhibition of degradation by proteases. The enzymatic activity of a protease is regulated by a balance among proteinases and their inhibitors. Recent studies demonstrated that transgenic mice that overexpress the PAI-1 showed more marked lung fibrosis in response to bleomycin than wild-type mice, whereas PAI-1 knockout mice are relatively protected (34) , emphasizing the role of serpin in extracellular matrix accumulation. It is also becoming clear that serpins inhibit critical cellular processes such as adhesion, migration, free radical production, and even apoptosis (35, 36) .
Detailed functional analysis of megsin is now under investigation.
In conclusion, megsin is a new serpin protein expressed predominantly in mesangial cells. The expression levels of megsin paralleled mesangial proliferation in vivo. Megsin could be the first biological marker for injured mesangial cells, which renders this molecule a high potential from the diagnostic perspective of glomerular diseases. Furthermore, marked upregulation of megsin in the injured mesangium suggests that megsin may play some roles in the pathogenesis of glomerulosclerosis. Studies of megsin might thus open up the way for future therapeutic approaches to treat various glomerular disorders. 
